Molecular characteristics predict clinical outcomes: Prospective trial correlating response to the EGFR tyrosine kinase inhibitor gefitinib with the presence of sensitizing mutations in the tyrosine binding domain of the EGFR gene

  • Naiyer A. Rizvi
  • , Valerie Rusch
  • , William Pao
  • , Jamie E. Chaft
  • , Marc Ladanyi
  • , Vincent A. Miller
  • , Lee M. Krug
  • , Christopher G. Azzoli
  • , Manjit Bains
  • , Robert Downey
  • , Raja Flores
  • , Bernard Park
  • , Bhuvanesh Singh
  • , Maureen Zakowski
  • , Robert T. Heelan
  • , Ronglai Shen
  • , Mark G. Kris

Research output: Contribution to journal › Article › peer-review

62 Scopus citations

Fingerprint

Dive into the research topics of 'Molecular characteristics predict clinical outcomes: Prospective trial correlating response to the EGFR tyrosine kinase inhibitor gefitinib with the presence of sensitizing mutations in the tyrosine binding domain of the EGFR gene'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry